相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antioxidant, Anti-Inflammatory, and Metabolic Properties of Tocopherols and Tocotrienols: Clinical Implications for Vitamin E Supplementation in Diabetic Kidney Disease
Angelo Di Vincenzo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
High Dose Vitamin E Attenuates Diabetic Nephropathy via Alleviation of Autophagic Stress
Yuxue Zhao et al.
FRONTIERS IN PHYSIOLOGY (2019)
Tocotrienol-rich vitamin E improves diabetic nephropathy and persists 6-9 months after washout: a phase IIa randomized controlled trial
Gerald Chen Jie Tan et al.
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM (2019)
Individual and Combined Relationship between Reduced eGFR and/or Increased Urinary Albumin Excretion Rate with Mortality Risk among Insulin-Treated Patients with Type 2 Diabetes in Routine Practice
Uchenna Anyanwagu et al.
KIDNEY DISEASES (2019)
The global burden of kidney disease and the sustainable development goals
Valerie A. Luyckx et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2018)
Targeting TGF-β Signaling in Kidney Fibrosis
Yoshitaka Isaka
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Tocotrienol-Rich Vitamin E from Palm Oil (Tocovid) and Its Effects in Diabetes and Diabetic Nephropathy: A Pilot Phase II Clinical Trial
Suzanne May Quinn Tan et al.
NUTRIENTS (2018)
What can target kidney fibrosis?
Irina A. Leaf et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)
Comparison of World Health Organization and Asia-Pacific body mass index classifications in COPD patients
Jeong Uk Lim et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2017)
Diabetic Kidney Disease Challenges, Progress, and Possibilities
Radica Z. Alicic et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Proteomics for prediction of disease progression and response to therapy in diabetic kidney disease
Michelle J. Pena et al.
DIABETOLOGIA (2016)
Vitamin E therapy beyond cancer: Tocopherol versus tocotrienol
Hong Yong Peh et al.
PHARMACOLOGY & THERAPEUTICS (2016)
Serum TGF-β1 as a Biomarker for Type 2 Diabetic Nephropathy: A Meta-Analysis of Randomized Controlled Trials
Xin Mou et al.
PLOS ONE (2016)
Is vitamin E supplementation effective in reducing mortality related to cardiovascular events in people with type 2 diabetes mellitus? A systematic review
Nirav Patel et al.
IJC METABOLIC & ENDOCRINE (2016)
Validation of a HPLC/FLD Method for Quantification of Tocotrienols in Human Plasma
Hui-Ling Che et al.
INTERNATIONAL JOURNAL OF ANALYTICAL CHEMISTRY (2015)
Diabetic Kidney Disease: Pathophysiology and Therapeutic Targets
Stephanie Toth-Manikowski et al.
JOURNAL OF DIABETES RESEARCH (2015)
Influence of Vitamin E Supplementation on Glycaemic Control: A Meta-Analysis of Randomised Controlled Trials
Renfan Xu et al.
PLOS ONE (2014)
Protective effects of tocotrienols against lipid-induced nephropathy in experimental type-2 diabetic rats by modulation in TGF-β expression
Shabeena Siddiqui et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
A study of the natural history of diabetic kidney disease (DKD)
Nagi Altemtam et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
The 21st Century Form of Vitamin E - Tocotrienol
Jayeeta Bardhan et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
P. L. Drury et al.
DIABETOLOGIA (2011)
Effects of vitamin E supplementation on glycaemic control in type 2 diabetes: systematic review of randomized controlled trials
N. Suksomboon et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2011)
Tocotrienols, the vitamin E of the 21st century: Its potential against cancer and other chronic diseases
Bharat B. Aggarwal et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Comparative antioxidant activity of tocotrienols and the novel chromanyl-polyisoprenyl molecule FeAox-6 in isolated membranes and intact cells
Paola Palozza et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2006)
Circulating vitamin E, transforming growth factor β1, and the association with renal disease susceptibility in two racial groups with type 2 diabetes
K Zitouni et al.
KIDNEY INTERNATIONAL (2005)
Modulation of the transforming growth factor beta 1 by vitamin E in early nephropathy
C Cojocel et al.
MEDICAL PRINCIPLES AND PRACTICE (2005)
Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes - Results of the HOPE study and MICRO-HOPE substudy
E Lonn et al.
DIABETES CARE (2002)
分享论文
